Results 141 to 150 of about 1,208 (169)

Quinoa Improves Non‐Alcoholic Fatty Liver Disease by Regulating the Ras‐PLD Pathway to Activate Autophagy

open access: yesFood Science &Nutrition, Volume 13, Issue 12, December 2025.
Quinoa alleviates liver injury, glucose/lipid metabolic disorders, and insulin resistance in high‐fat diet‐induced NAFLD mice. Mechanistically, it acts by inhibiting the Ras‐PLD signaling pathway, activating autophagy, and regulating key related protein/gene expressions, as validated via network pharmacology, transcriptomics, and in vivo experiments ...
Yuelin Zhang   +6 more
wiley   +1 more source

Hibiscus rosa‐sinensis: A Multifunctional Flower Bridging Nutrition, Medicine, and Molecular Therapeutics

open access: yesFood Science &Nutrition, Volume 13, Issue 12, December 2025.
H. rosa‐sinensis bioactives modulate oxidative and inflammatory pathways. Myricetin and rutin show strong α‐glucosidase and SOD binding affinity. Exhibits safe, multifunctional use in health, food and nutraceuticals. ABSTRACT Hibiscus rosa‐sinensis, commonly known as the shoe flower, thrives in tropical and subtropical regions across South China, Asia,
Hassan Raza   +6 more
wiley   +1 more source

Coffee Consumption and Risk of Incident Gastrointestinal Disease: A Large Prospective Cohort Study

open access: yesFood Science &Nutrition, Volume 13, Issue 12, December 2025.
In a large prospective cohort, unsweetened coffee consumption demonstrated a U‐shaped association with a reduced risk of multiple gastrointestinal diseases and attenuated genetic susceptibility, whereas adding sweeteners, particularly artificial ones, diminished these protective effects.
Shenxuan Zhou   +6 more
wiley   +1 more source

Antioxidant and Hepatotoxicity Ameliorative Potential of Mentha canadensis Leaves Against Paracetamol‐Induced Hepatic Damage in Mice

open access: yesFood Science &Nutrition, Volume 13, Issue 12, December 2025.
This study demonstrates the hepatoprotective potential of M. canadensis leaf methanolic extract (MCLME), through its antioxidant and anti‐inflammatory activities, against paracetamol‐induced liver injury in mice. MCLME significantly reduced serum liver biomarkers, restored glutathione and IL‐6 levels, and improved hepatic histology, indicating membrane
Asma Ul Husna Biswas   +9 more
wiley   +1 more source

Extracellular Vesicles in Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities

open access: yesiNew Medicine, Volume 1, Issue 1, December 2025.
The role of extracellular vesicles (EVs) in the progression of nonalcoholic fatty liver disease (NAFLD). Donor cells release EVs containing various molecules such as cholesterol, ceramide, sphingomyelin, miRNA, DNA, proteins, and lipids. These EVs are taken up by multiple recipient cells including Kupffer cells, adipocytes, β cells, adipose tissue ...
Yunsheng Dong   +12 more
wiley   +1 more source

In Vitro Assessment of Drug‐Induced Liver Injury Using Three‐Dimensional Cultured HepaSH Cells Derived From Chimeric Mouse Model With Humanized Liver

open access: yesJournal of Applied Toxicology, Volume 45, Issue 12, Page 2641-2653, December 2025.
ABSTRACT Drug‐induced liver injury (DILI) is a serious adverse event and a common cause of postmarketing drug withdrawal. Despite nonclinical assessments of DILI risk, which are predominantly conducted in experimental animals, DILI remains a frequent adverse event, highlighting the need to improve nonclinical assessments.
Xingming Liu   +7 more
wiley   +1 more source

Association of maternal biliary disease with hepatopancreatobiliary morbidity in offspring

open access: yesJournal of Pediatric Gastroenterology and Nutrition, Volume 81, Issue 6, Page 1422-1430, December 2025.
Abstract Objectives Maternal biliary disease is common, but the link with offspring hepatopancreatobiliary disease has not been studied. We assessed the association between maternal biliary disease and pediatric hepatopancreatobiliary morbidity. Methods We conducted a retrospective cohort study of 1,271,864 children born between 2006 and 2022 in Quebec,
Nathalie Auger   +6 more
wiley   +1 more source

Initial Clinical Experience With the Oral Cholate Challenge Test: Results From the 2023–2024 Early Access Program

open access: yesLiver International Communications, Volume 6, Issue 4, December 2025.
ABSTRACT The oral cholate challenge test of liver health, intended for use in compensated advanced chronic liver disease, was launched through an Early Access Program (EAP) in 2023–2024. Tests were provided to 16 clinicians at five liver centres across the US. The tested patients (n = 129) represented a range of etiologies and stages of disease.
Stuart C. Gordon   +3 more
wiley   +1 more source

Ovarian Aging: Mechanisms, Age‐Related Disorders, and Therapeutic Interventions

open access: yesMedComm, Volume 6, Issue 12, December 2025.
A comprehensive overview of the molecular mechanisms underlying ovarian aging, its association with age‐related diseases, and potential therapeutic interventions. Ovarian aging involves DNA damage, mitochondrial dysfunction, oxidative stress, telomere attrition, and follicular depletion, driving age‐related infertility, menopause, and multiple systemic
Xingyu Liu   +4 more
wiley   +1 more source

Interventional gastroenterology in oncology

Ca-A Cancer Journal for Clinicians, 2023
Vaibhav Wadhwa
exaly  

Home - About - Disclaimer - Privacy